These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35910363)

  • 61. Herbal small RNAs in patients with COVID-19 linked to reduced DEG expression.
    Qiao X; Huang F; Shi X; Deng X; Zhang C; Mei S; Wang Z; Zhou C; Jiang C; Tan X
    Sci China Life Sci; 2023 Jun; 66(6):1280-1289. PubMed ID: 36738432
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Efficacy and safety of Reyanning mixture in patients infected with SARS-CoV-2 Omicron variant: A prospective, open-label, randomized controlled trial.
    Xu X; Zhou S; Chen C; Li J; Wu H; Jin G; Zhou J; Wang G; Cao M; Sun D; Zhang W; Peng W; Pu Y; Sun Y; Fang B; Xu J
    Phytomedicine; 2023 Jan; 108():154514. PubMed ID: 36334390
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clinical efficacy of Jingyin granules, a Chinese patent medicine, in treating patients infected with coronavirus disease 2019.
    Chen B; Yu X; Zhang L; Huang W; Lyu H; Xu Y; Shen J; Yuan W; Fang M; Li M; Gao Y
    Phytomedicine; 2023 Jan; 108():154496. PubMed ID: 36288651
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Traditional Chinese Medicine JingYinGuBiao Formula Therapy Improves the Negative Conversion Rate of SARS-CoV2 in Patients with Mild COVID-19.
    Chen B; Geng P; Shen J; Liangpunsakul S; Lyu H; Zhang J; Yang Y; Zhang L; Xu Y; Dong C; Wang Y; Xue Y; Zhang W; Liu H; Li M; Gao Y
    Int J Biol Sci; 2022; 18(15):5641-5652. PubMed ID: 36263182
    [No Abstract]   [Full Text] [Related]  

  • 65. Practice and principle of traditional Chinese medicine for the prevention and treatment of COVID-19.
    Zhao L; Tian C; Yang Y; Guan H; Wei Y; Zhang Y; Kang X; Zhou L; Li Q; Ma J; Wan L; Zheng Y; Tong X
    Front Med; 2023 Dec; 17(6):1014-1029. PubMed ID: 38157191
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Neuroprotective potentials of ferulic acid against intracerebral hemorrhage COVID-19 through using network pharmacology approach and molecular docking analysis.
    Dong Q; Tan Y; Tang G; Wu Z; Li A; Qin X; Li S; Liao H; Xiao J; Huang Q; Yang J; Qin Y
    Curr Res Toxicol; 2023; 5():100123. PubMed ID: 37731942
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Traditional Vietnamese Medicine Containing Garlic Extract for Patients With Non-severe COVID-19: A Phase-II, Double-Blind, Randomized Controlled Trial.
    Giang TV; Hoa LNM; Hien TT; Cuong QD; Cap NT; Lam Vuong N; Thach PN
    Cureus; 2023 Jul; 15(7):e42484. PubMed ID: 37637574
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Emergency Protective Measures and Strategies of COVID-19: From Lifestyle to Traditional Chinese Medicine.
    Hu C
    Clin Complement Med Pharmacol; 2023 Sep; 3(3):100089. PubMed ID: 37342312
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies.
    Xu SW; Ilyas I; Weng JP
    Acta Pharmacol Sin; 2023 Apr; 44(4):695-709. PubMed ID: 36253560
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Role of Traditional Chinese Medicine in Treating Severe or Critical COVID-19: A Systematic Review of Randomized Controlled Trials and Observational Studies.
    Li M; Zhu H; Liu Y; Lu Y; Sun M; Zhang Y; Shi J; Shi N; Li L; Yang K; Sun X; Liu J; Ge L; Huang L
    Front Pharmacol; 2022; 13():926189. PubMed ID: 35910363
    [No Abstract]   [Full Text] [Related]  

  • 71. Efficacy and safety of chinese herbal medicine for treating mild or moderate COVID-19: A systematic review and meta-analysis of randomized controlled trials and observational studies.
    Zhu H; Li M; Tian C; Lai H; Zhang Y; Shi J; Shi N; Zhao H; Yang K; Shang H; Sun X; Liu J; Ge L; Huang L
    Front Pharmacol; 2022; 13():988237. PubMed ID: 36160412
    [No Abstract]   [Full Text] [Related]  

  • 72. Efficacy and Safety of Traditional Chinese Medicine in Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis.
    Wang H; Xu B; Zhang Y; Duan Y; Gao R; He H; Li X; Li J
    Front Pharmacol; 2021; 12():609213. PubMed ID: 34421581
    [No Abstract]   [Full Text] [Related]  

  • 73. Use of traditional Chinese medicine for the treatment and prevention of COVID-19 and rehabilitation of COVID-19 patients: An evidence mapping study.
    Li Y; Qin Y; Chen N; Ge L; Wang Q; Aboudou T; Han J; Hou L; Cao L; Li R; Li M; Mi N; Xie P; Wu S; Hu L; Li X; Song Z; Ji J; Zhang Z; Yang K
    Front Pharmacol; 2023; 14():1069879. PubMed ID: 36744266
    [No Abstract]   [Full Text] [Related]  

  • 74. Evidence Mapping of 23 Systematic Reviews of Traditional Chinese Medicine Combined With Western Medicine Approaches for COVID-19.
    Zhang T; Li X; Chen Y; Zhao L; Tian J; Zhang J
    Front Pharmacol; 2021; 12():807491. PubMed ID: 35197851
    [No Abstract]   [Full Text] [Related]  

  • 75. A Protocol of a Guideline to Establish the Evidence Ecosystem of Acupuncture.
    Wang Q; Li N; Li J; He Y; Li Y; Zhong D; Liu X; Fan J; Jin R; Kang D; Zhang Y
    Front Med (Lausanne); 2021; 8():711197. PubMed ID: 35252220
    [TBL] [Abstract][Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.